Search All News
Columbia University COVID researchers are working to improve coronavirus testing, find new antivirals, and develop new ways to prevent transmission.
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
- January 3, 2020
Some compounds found in many personal care products displace natural fat-like molecules in skin cells, which may explain how they cause an allergic skin rash.
- December 18, 2019
Columbia scientists have captured the first images of a new gene editing tool that could improve upon existing CRISPR-based tools.
- December 17, 2019
Brush up on 2019's most newsworthy health findings from researchers across Columbia University Irving Medical Center.
- December 3, 2019
With new microneedles in development at Columbia University, delivering precise doses of drugs to the inner ear without risking permanent hearing damage may soon be possible.
- November 27, 2019
The first-ever detailed images of a malaria protein, a key modulator of drug resistance, show how the parasite evades antimalarials—and may help scientists find ways to restore the drugs’ potency.
- November 14, 2019
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
- November 1, 2019
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
- October 21, 2019
A new study suggests that many different immune cells, not just T cells, are involved in triggering multiple sclerosis (MS).